Wells Fargo
LNAI

Wells Fargo’s Lunai Bioworks LNAI Stock Holding History

Wells Fargo’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30
Closed -$701 – 7343
2025
Q2 		$701 Sell
30
-711
-96% -$19.9K ﹤0.01% 6343
2025
Q1 		$32.2K Buy
741
+2
+0.3% +$128 ﹤0.01% 5540
2024
Q4 		$49.4K Buy
739
+512
+226% +$34K ﹤0.01% 5489
2024
Q3 		$8.79K Buy
227
+5
+2% +$347 ﹤0.01% 5825
2024
Q2 		$31K Buy
222
+218
+5,450% +$29.7K ﹤0.01% 5455
2024
Q1 		$779 Hold
4
– – ﹤0.01% 6207
2023
Q4 		$910 Buy
4
+1
+33% +$274 ﹤0.01% 6248
2023
Q3 		$956 Sell
3
-3
-50% -$456 ﹤0.01% 6215
2023
Q2 		$276 Sell
6
-37
-86% -$2.84K ﹤0.01% 6611
2023
Q1 		$3.18K Buy
+43
New +$3.78K ﹤0.01% 6152
2022
Q4 		– Hold
0
– – – 7677
2022
Q3 		– Sell
-3
Closed -$547 – 7232
2022
Q2 		$0 Buy
3
+2
+200% +$915 ﹤0.01% 7358
2022
Q1 		$1K Hold
1
– – ﹤0.01% 6851
2021
Q4 		$1K Hold
1
– – ﹤0.01% 7060
2021
Q3 		$1K Hold
1
– – ﹤0.01% 6777
2021
Q2 		$0 Sell
1
-59
-98% -$19.2K ﹤0.01% 7333
2021
Q1 		$17K Sell
60
-217
-78% -$63.8K ﹤0.01% 6200
2020
Q4 		$65K Sell
277
-215
-44% -$54.3K ﹤0.01% 5510
2020
Q3 		$141K Sell
492
-31
-6% -$9.77K ﹤0.01% 5121
2020
Q2 		$176K Buy
523
+115
+28% +$34.7K ﹤0.01% 4975
2020
Q1 		$98K Buy
408
+155
+61% +$46.1K ﹤0.01% 5073
2019
Q4 		$101K Buy
253
+19
+8% +$8.35K ﹤0.01% 5292
2019
Q3 		$103K Buy
234
+34
+17% +$13K ﹤0.01% 5309
2019
Q2 		$72K Buy
+200
New +$97.5K ﹤0.01% 5430

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo's LNAI Position: Q3 2025 in Review

Wells Fargo sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 30 shares — an estimated $701 sold.

Wells Fargo first reported a position in LNAI in Q2 2019 and held it in 23 quarters. The position peaked at $176K in Q2 2020. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

  • Wells Fargo reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 30 Lunai Bioworks shares in Q3 2025, an estimated $701.
  • Wells Fargo first reported a position in Lunai Bioworks in Q2 2019 and held it in 23 quarters.
  • Wells Fargo's Lunai Bioworks position peaked at $176K in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.